We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type



8 results found


Borden Ladner Gervais LLP | Canada | 10 Aug 2016

Patent held Invalid for Ambiguity and Obviousness

Pollard challenged the validity of Scientific Games' (the successor to BABN) patent. Scientific Games counterclaimed with allegations of infringement


Borden Ladner Gervais LLP | Canada | 27 Jul 2016

Appeal of NOC Proceeding Dismissed as Moot, Despite Ongoing Section 8 Proceeding

Amgen was unsuccessful in a proceeding brought pursuant to the NOC Regulations. It appealed that decision. Apotex brought the within motion to


Borden Ladner Gervais LLP | Canada | 14 Jul 2016

Solicitors for the defendants are not removed as counsel even though the plaintiffs had contacted them about representation years prior

The Federal Court has upheld a decision to not remove counsel as solicitors of record for the defendants. The plaintiffs had argued that when they


Borden Ladner Gervais LLP | Canada | 27 Jan 2016

Standard of Review of Palpable and Overriding Error Not Applied in Appeal from Rule 51 Appeal

This is an appeal from the Federal Court's (FC) decision (2015 FC 797), which upheld the Prothonotary's decision allowing the generic Respondent's


Borden Ladner Gervais LLP | Canada | 4 May 2015

Federal Court of Appeal clarifies the standard of review for an appeal of a discretionary interlocutory order

This is a lawsuit for infringement of industrial designs. Imperial had appealed from an interlocutory order of the Federal Court (2013 FC 1189


Borden Ladner Gervais LLP | Canada | 3 Jun 2013

Intellectual property weekly abstracts bulletin

Bayer sought to prohibit the Minister of Health from issuing a Notice of Compliance to Cobalt for a generic version of Bayer’s oral contraceptive

Previous page 1 Next page